ALPPS Combined With Tislelizumab in Liver Malignancy

Clinical trial NCT04996446 · UNKNOWN

Trial details

NCT number: NCT04996446
Sponsor: Fudan University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Malignant Tumors

Start date: 2020-08-01
Primary completion: 2023-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.